Sectra Amplifier Marketplace

Pathology

Welcome to the Sectra Amplifier Marketplace for pathology. Here, you will find pathology AI applications that can be seamlessly integrated with your Sectra diagnostic viewer. The applications listed have either been validated and verified for use at the point of care through CE marking and/or FDA clearance, or can be used as laboratory-validated tests where applicable. The pathology ecosystem consists of both Amplifier Partners and Amplifier Integrators.

Find out more about the different partnerships on the About page. All content related to the applications is provided by the respective AI vendors. Browse the available applications below and contact us if you would like to find out more.

Research only | H&E

AIRAProstate is a deep learning based image analysis solution for detection of malignancy and Gleason grading in whole slide images (WSI) of prostatic core needle biopsies.

Paige Breast is a digital diagnostic aid for assisting pathologists with detecting and classifying carcinoma and atypical lesions on H&E stained WSIs of breast tissue.

PANProfiler Breast (ER,PR,HER2)

The PANProfiler Breast (ER, PR, HER2) returns accurate, rapid ER, PR and HER2 breast tumor biomarker profiles directly from analyzing H&E images.

Primaa CLEO BREAST

Research only | H&E

CLEO BREAST employs AI-based algorithms to assist pathologists in their diagnostic journey, integrating AI-enhanced tools including detection of critical biomarkers, such as Invasive Carcinoma, Metastases, Mitoses, Calcifications, and Emboli.

Aiosyn Mitosis Breast

Aiosyn Mitosis Breast is an AI-powered solution to aid pathologists with the identification of mitotic figures in H&E sections. Slides are prepared as usual, and the algorithm analyzes images once uploaded to the platform.

ArteraAI Breast

ArteraAI Breast provides 5- and 10-year risks of distant metastasis and ArteraAI risk score for HR+/HER2-, N0 or N1, early stage invasive breast cancer patients, to assist physicians with prognostic risk-based decisions with other clinical factors.

Research only | H&E

BRCAura RUO is a deep learning software intended to assist researchers in the detection of morphological features associated with BRCA1 or BRCA2 mutations.

Cellda® Prostate

Research only | IHC

Cellda® Prostate assists pathologists in the review of scanned whole slide images (WSI) from prostate needle biopsies. The software identifies regions with malign tissue and provides basis for high diagnostic sensitivity and specificity.

Clinical AI Model for Breast Cancer: ER

Intended for use with digitized images of ER stained normal and cancerous human breast tissue to support the detection of tumor epithelium and scoring of ER positive and negative cells of epithelial origin from WSI or the selected image areas.

Research only | CMV

Apaz Medical CMV Detection Module is an AI-based clinical decision support software that automatically detects Cytomegalovirus (CMV)-infected cells in immunohistochemistry-stained digital pathology images. It integrates with Sectra PACS to support pathologists and improve diagnostic efficiency.

DeepPath™–LYDIA

DeepPath™–LYDIA is an AI-powered decision support system for detecting metastases on digitised microscope slides of H&E stained Lymph-Node sections from patients with melanoma as well as breast, colon and lung cancer.

DiaDeep Kwant HER2

Research only | HER2

Focus on patient complex cases, not on biomarker quantification! Kwant enables pathologists to accurately assess HER2 on whole slide images.

ER APP, Breast Cancer

The ER APP automatically analyses whole slide images of breast cancer tissue stained by estrogene receptor and provide objective results for the % of positive cells, H-score and Allred score.

Franklin Digital Prostate

Research only | H&E

The product identifies suspected clinical findings and technical artefacts in scanned Whole Slide Images (WSI) from prostate needle biopsies and transurethral resection of the prostate prepared from Hematoxylin & Eosin (H&E) stained formalin-fixed paraffin embedded (FFPE) tissue.

Research only | H&E

Histofy MitPro is a next-generation AI solution capable of detecting, precisely quantifying and profiling mitosis across various cancer types within specific regions of interest (RoIs) and entire whole-slide images (WSIs).

Histotype Px® Colorectal

Histotype Px® Colorectal is an aid in determining the survival prognosis for patients with R0 stage II and III colorectal adenocarcinoma.

AI-powered, deployed in digital workflows & used by leading physicians, health systems & diagnostic providers in everyday practice, Ibex Breast is a clinical-grade solution assisting pathologists in accurate diagnosis of breast biopsies & excisions.

identify.bio PSx2

Research only | Pap stain

The Pap Smear Pre Screening Tool (PSx2) is an AI-assisted cervical cytology pre-screening application that analyses LBS Pap smear WSI to identify abnormal cells and microorganisms, helping pathologists prioritize review, improve workflow efficiency, and reduce interpretation time.

Imagene NSCLC Panel

Research only | H&E

ImageneOI is an AI-based biomarker profiling solution providing rapid NSCLC biomarker status from the H&E biopsy image alone. Currently offering profiling of EGFR mutations and ALK fusions. A biomarker status report is provided within minutes.

Mindpeak Breast ER/PR RoI

Mindpeak Breast ER/PR RoI is a software for automated image analysis of digital histopathology images of human invasive mamma carcinoma tissue samples without the need for manual fine-tuning it to your lab.

myStage Dx is a software-only in vitro diagnostic (IVD) device intended to assess the risk of distant metastasis within nine years from diagnosis in adult patients with stage II-III, node-positive, ER-positive, HER2-negative breast cancer.

Pathol.AI Stomach H. Pylori

Research only | H&E

Identifying Helicobacter pylori (H. Pylori) on single auto-focus Haemotoxylin and Eosin (H&E) stained whole-slide images (WSI)

Research only | H&E

Clinical-decision-support system for the classification of body tissues as benign, inflamed, or dysplastic, and the detection of malignant areas to screen, diagnose, and report on colorectal cancers.

MFDS | ER, HER2, KI67 & PR

Qanti® IHC is designed to assist anatomic pathologists in the quantitative interpretation of IHC for various biomarkers, including ER, PR, HER2 and Ki-67. Qanti® IHC can analyze a WSI in under 5 minutes and display more than 3 million cells at once.

SlideRightQA is an AI-powered software that automates quality review of whole slide images in digital pathology, ensuring only high-quality, diagnostically reliable images reach pathologists while streamlining workflows and supporting continuous process improvement.

Stratipath Breast

Stratipath Breast is an AI-based decision support tool for risk stratification of primary invasive breast cancer from H&E-stained histopathology images of surgical resection specimen.

TriMe Mitosis Detection

This AI‑based clinical decision‑support system analyzes the entire set of H&E histology slides to detect mitotic figures with high accuracy. It systematically identifies and ranks contiguous high‑power field regions with the highest mitotic density and assigns confidence scores to each detected mitosis, enabling transparent, traceable review while preserving pathologist oversight and final diagnostic responsibility.

AIRAQc is a deep learning based solution crucial in preanalytical digital pathology workflows. The solution automates and speeds up preanalytical quality checks of whole slide images.

Paige Breast Lymph Node

Paige Breast Lymph Node is designed to aid pathologists in the detection of metastases in breast lymph node, guiding pathologists to areas suspicious for metastases including ITCs and small challenging micromets to improve diagnostic confidence.

Paige Prostate Biomarker Panel

Paige Prostate Biomarker Panel is comprised of four AI models used to identify biomarkers including Androgen Receptor (AR) amplification, TP53, RB1 and PTEN mutations, based on the assessment of H&E-stained primary and metastatic prostate samples.

Paige Prostate Detect

Paige Prostate Detect assists pathologists in the detection of suspicious foci, highlighting the region of interest with the highest likelihood of harboring cancer to help improve diagnostic sensitivity.

Paige Prostate Grade and Quantify

Paige Prostate Grade & Quantify uses a proprietary tissue map to categorize areas suspicious for cancer by Gleason pattern to assist pathologists in evaluating values for overall tumor percentage and tumor length.

Paige Prostate Perineural Invasion

Paige Prostate Perineural Invasion (PNI) aids pathologists in identifying the presence of suspicious foci around nerve fibers within the prostate for detection of PNI in core needle biopsies.

Primaa CLEO SKIN

CLEO SKIN uses AI for H&E stained skin biopsies and excised tissues. It aids pathologists by detecting key biomarkers like Lesions & Classification, Dimensions, margins, Mitoses and Perineural Invasion, optimizing diagnostic precision & efficiency.

AiosynQC is an AI-powered solution for automated quality control (QC) of H&E and IHC digital histology slides. Slides are prepared as usual, and AiosynQC analyzes images once uploaded to the platform.

ArteraAI Breast Cancer Assay

IVDR Intended Purpose: The ArteraAI Breast Cancer Assay is an in vitro diagnostic medical device software device based on artificial intelligence (AI) that assesses physician-provided clinical variables and whole slide images (WSI) of Breast Resection specimens to provide risk estimates of Distant Metastasis for patients with HR+/ HER2- breast cancer. It is intended to assist clinicians with risk-based decisions in patients with HR+/HER2-, N0 or N1, early stage invasive breast cancer.

ArteraAI Prostate

ArteraAI Prostate is a software only device intended to analyze scanned histopathology whole slide images from treatment-naïve prostate core needle biopsies. It provides 10-year risks of distant metastasis and prostate cancer specific mortality.

ArteraAI Prostate Biopsy Assay

ArteraAI Prostate Biopsy Assay is an IVD software based on AI that assesses clinical variables and H&E stained WSIs of prostate biopsies to provide risk estimates of disease prognosis and prediction of risk appropriate treatment benefit

Clinical AI Model for Breast Cancer: Ki67

Intended for use with digitized images of Ki67 stained normal and cancerous human breast tissue to support the detection of tumor epithelium and scoring of Ki67 positive and negative cells of epithelial origin from WSI or the selected image areas.

Clinical AI Model for Breast Cancer: PR

Intended for use with digitized images of PR stained normal and cancerous human breast tissue to support the detection of tumor epithelium and scoring of PR positive and negative cells of epithelial origin from WSI or the selected image areas.

Clinical AI Model for Lung Cancer: PD-L1

Intended for use with digital images of PD-L1-stained cancerous lung tissue with NSCLC of human specimens to support the detection of tumor epithelium and scoring of PD-L1 positive and negative cells of epithelial origin from WSI and displays results of image analysis.

Clinical AI Model for Prostate Cancer: Gleason Grade Groups

Intended for use with digital images of H&E-stained cancerous prostate tissue with malignant neoplasm of human prostate specimens to support the detection of tumor epithelium and assessing Gleason patterns from WSI and displays results of image analysis.

DiaDeep Kwant Ki67

Research only | KI67

Focus on patient complex cases, not on biomarker quantification! Kwant enables pathologists to accurately assess Ki67 across the entire slide or within three hotspots.

Research only | ER

Focus on patient complex cases, not on biomarker quantification! Kwant enables pathologists to accurately assess ER on whole slide images.

Research only | PR

Focus on patient complex cases, not on biomarker quantification! Kwant enables pathologists to accurately assess PR on whole slide images.

DiaKwant™ Mitosis

Research only | H&E

DiaKwant™ Mitosis segments invasive tumor areas, quantifies mitotic figures across the whole slide, and reports mitotic counts with hotspot detection, heatmaps, and overlays for clear visualization.

DiaKwant™ PD-L1

Research only | PD-L1

DiaKwant™ PD-L1 automatically quantifies PD-L1 expression by distinguishing tumor and immune cells, providing full-slide TPS and CPS scores with interactive heatmaps and overlays. No intervention or manual selection

HER2 APP, Breast Cancer

HER2 APP analyses the whole slide, using the Visiopharm's HER2-Connect algorithm to asses the membrane completeness, outputting a continious connectivity score and the discrete 0, 1+, 2+, and 3+ score.

Ibex Breast HER2

Research only | HER2

AI-powered, deployed in digital workflows & used by leading physicians, health systems & diagnostic providers in everyday practice, Ibex Breast HER2 is a clinical-grade solution assisting pathologists in accurate diagnosis of breast biopsies & excisions.

AI-powered, deployed in digital workflows and used by leading physicians, health systems and diagnostic providers in everyday practice, Ibex Gastric is a clinical-grade solution that assists pathologists in accurate diagnosis of gastric biopsies.

AI-powered, deployed in digital workflows & used by leading physicians, health systems & diagnostic providers in everyday practice, Ibex Prostate is a clinical-grade solution assisting pathologists in providing accurate diagnosis of prostate biopsies.

Ki-67 APP, Breast Cancer

Ki-67 APP analyzes the whole slide, automatically identifying patient vs control tissue, detects nuclei in the invasive tumor only and returning a proliferation index for the entire tumor region. It can be combined with the Hot Spot detection APP.

Metastasis Detection, AI

The APP automtically analyses whole slides to detect micro- and macro metastisis that are not easily noticed in lymph nodes associated with breast and colon adenocarcinoma, stained with H&E. Detected areas are categories by likelihood.

Mindpeak Breast HER2

Research only | HER2

Mindpeak Breast HER2 is a 0-click AI solution software for automated image analysis of digital histopathology images of human invasive mamma carcinoma tissue samples without the need for manual fine-tuning it to your lab.

Mindpeak Breast HER2 RoI

Mindpeak Breast HER2 RoI is a software for automated image analysis of digital histopathology images of human invasive mamma carcinoma tissue samples without the need for manual fine-tuning it to your lab.

Mindpeak Breast Ki-67 RoI

Mindpeak Breast Ki-67 RoI is a software for automated image analysis of digital histopathology images of human invasive mamma carcinoma tissue samples without the need for manual fine-tuning it to your lab.

Mindpeak Breast Ki67 4R

Mindpeak Breast Ki-67 4R is an AI-based software for automated image analysis of digital histopathology images of human invasive mamma carcinoma tissue samples without the need for manual fine-tuning it to your lab.

Mindpeak Breast Ki67 HS

Mindpeak Breast Ki-67 HS is an AI-based software for automated image analysis of digital histopathology images of human invasive mamma carcinoma tissue samples without the need for manual fine-tuning it to your lab.

Mindpeak Breast p53 RoI

Research only | p53

This AI tool quantifies p53 positive breast cancer cells and works out-of-the-box with real-world image variability in any lab without the need for manual fine-tuning per lab.

Mindpeak Breast ER/PR is an AI-based software for automated image analysis of digital histopathology images of human invasive mamma carcinoma tissue samples without the need for manual fine-tuning it to your lab.

Mindpeak Lung (NSCLC) PD-L1

Research only | PD-L1

Mindpeak Lung (NSCLC) PD-L1 is a 0-click AI solution for automated image analysis of digital histopathology images of non-small-cell lung carcinoma (NSCLC) tissue samples.

Mindpeak Lung (NSCLC) PD-L1 (SP263) RoI

The first AI solution for PD-L1 supports cancer experts in the challenging assessment of PD-L1 stained lung tissue. Mindpeak Lung (NSCLC) PD-L1 (SP263) RoI for NSCLC helps to achieve accurate results without the need of manual fine-tuning.

MSIntuit® Suite

MSIntuit Suite is a suite of products based on deep learning models intended to assist pathologists in ruling out patients with a microsatellite stable status in colorectal cancer, gastric cancer and endometrial cancer.

NephroPath GlomeruCount

Research only | H&E

NephroPath GlomeruCount is an AI-powered tool designed for precise glomerular quantification. It automatically identifies and classifies glomeruli as healthy or sclerotic and calculates the glomerular area and dimensions.

PD-L1 APP, NSCLC

PD-L1 APP analyzes the whole slide, automatically identifying patient vs control tissue, detecting nuclei in the invasive tumor and calculating the Tumor Positive Score (TPS) along with a Heatmap of the TPS.

PR APP, Breast Cancer

The PR APP automatically analyses whole slide images of breast cancer tissue stained by progesterone receptor and provide objective results for the % of positive cells, H-score and Allred score.

QAi Ki-67 Quant

Research only | KI67

Clinical-decision-support system for the detection of Ki-67 nuclei and the classification of body tissues responding positively or negatively to the biomarker in IHC slides

QAi Prostate Dx

Research only | H&E

Clinical-decision-support system for screening, diagnosing, and reporting on H&E-stained prostate core needle biopsy

RlapsRisk BC is an automated prognostic software intended to estimate the risk of experiencing a dRFI event after surgery under 5-years adjuvant endocrine therapy alone, for early non-metastatic, ER+/HER2-, invasive breast cancer adult patients.

View more